“EVERYONE'S AFRAID,” says Janice Miller, director, CME, Brown Medical School, Providence, R.I. “Pharmaceutical companies have their legal departments working overtime to protect themselves from the threat of a huge, multibillion-dollar fine. I don't know if that was the intent of the OIG [Office of Inspector General's Compliance Program Guidance for Pharmaceutical Manufacturers], but that's the result.”
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments